Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
Clinical trial NCT02094326 · COMPLETED
Trial details
- NCT number
- NCT02094326
- Sponsor
- Fundación Andaluza de Reumatología
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-10-01
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.